ÂÜÀòÂÒÂ×

Philip Sinclair serves as Vice President of Global Medical Affairs and Clinical Development in Interventional Oncology at Boston Scientific since August 2019, after previously holding the position of Vice President of Global Medical Affairs in the same division. Prior experience includes roles as Vice President of Medical Affairs and Senior Director of Medical Strategy and Operations at BTG plc from July 2013 to August 2019, as well as leadership positions in medical affairs at Nordion and Allphase Clinical Research. Additional advisory roles were undertaken at Atherochem and BioQuest Therapeutics, and early career experience includes positions in research consulting and R&D management. Educational credentials include a PhD in Toxicology, an MSc in Endocrinology, and a BSc in Animal Biology, all earned from the University of Guelph.